CTI BioPharma

-$0.04 (-1.48%) Today
+$0.01 (+0.37%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CTI BioPharma and other ETFs, options, and stocks.

About CTIC

CTI BioPharma Corp. is a biopharmaceutical company, which focuses on the development, acquisition and commercialization of novel targeted therapies for blood-related cancers. It focuses on evaluating pacritinib, its sole product candidate currently in active development, for the treatment of adult patients with myelofibrosis.

CEO
Adam R. Craig
Employees
23
Headquarters
Seattle, Washington
Founded
1991

CTIC Key Statistics

Market Cap
249.14M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
538.01K
High Today
$2.70
Low Today
$2.66
Open Price
$2.70
Volume
545.31K
52 Week High
$4.13
52 Week Low
$2.15

CTIC Earnings

-$0.23
-$0.15
-$0.08
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 9, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure